Results 181 to 190 of about 54,096 (328)

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

Leukemia, 2021
G. Abu-Zeinah, S. Krichevsky, Tatiana Cruz, Gabriela Hoberman, Diana Jaber, N. Savage, Claudia Sosner, E. Ritchie, J. Scandura, R. Silver   +9 more
semanticscholar   +1 more source

Clinical evaluation and outcome in heart failure patients receiving chemotherapy with different anti‐cancer agents

ESC Heart Failure, Volume 12, Issue 3, Page 1965-1976, June 2025.
Abstract Background The optimal strategy for modern chemotherapy should be based on a comprehensive approach for cancer patients with cardiovascular diseases. Therefore, cardio‐oncology has received increasing attention owing to the cardiotoxic effects of anti‐cancer therapies.
Tomiko Sunaga, Takahiro Okada, Yoshitaka Iso, Mio Ebato, Tsutomu Toshida, Shuichi Nawata, Hiroshi Suzuki, Mari Kogo   +7 more
wiley   +1 more source

No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis

Haematologica, 2013
Valentina Poletto, Laura Villani, Paolo Catarsi, Rita Campanelli, Margherita Massa, Alessandro M. Vannucchi, Vittorio Rosti, Giovanni Barosi   +7 more
doaj   +1 more source

Association of Pruritus With Comorbidities and Survival in Myeloproliferative Neoplasms: A Systematic Review of the Literature

JEADV Clinical Practice, Volume 4, Issue 2, Page 407-415, June 2025.
ABSTRACT Background Pruritus is a symptom frequently associated with systemic diseases, particularly hematological disorders. Objectives The aim of this study was to evaluate the association of pruritus with morbidity in myeloproliferative neoplasms (MPN).
J. Saucereau, E. Brenaut, A. S. Ficheux, L. Misery, C. Le Gall‐Ianotto   +4 more
wiley   +1 more source

Unusual cause of dyspnea in patient with Myelofibrosis: The Ruxolitinib lung

Respiratory Medicine Case Reports
Although pulmonary complications are frequent in patients suffering from hematological diseases, secondary pulmonary alveolar proteinosis is a very rare complication of myelofibrosis.
Antoine El Kik, Maarten Vander Kuylen, Benjamin Bailly, Jennifer Fallas, Benjamin Bondue   +4 more
doaj  

Idiopathic hypoparathyroidism associated with stable untreated myelofibrosis. [PDF]

, 1983
H. K. L. Simpson, CW Howden, Henry L. Elliott, T J Thomson   +3 more
openalex   +1 more source

Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera

Pharmacology Research &Perspectives, Volume 13, Issue 3, June 2025.
ABSTRACT Ropeginterferon alfa‐2b (ropeg) represents a new‐generation interferon‐based therapy approved for polycythaemia vera (PV) treatment. This study aimed to elucidate its population pharmacokinetics‐pharmacodynamics (PopPK‐PD) and exposure‐response (E‐R) relationships.
Albert Qin, Kazuya Shimoda, Shanshan Suo, Rongfeng Fu, Keita Kirito, Daoxiang Wu, Jason Liao, Haoqi Chen, Lei Wu, Xia Su, Yucheng Gao, Toshiaki Sato, Yaning Li, Jingjing Zhang, Weihong Shen, Wei Wang, Lei Zhang, Jie Jin, Norio Komatsu   +18 more
wiley   +1 more source

Myelofibrosis, Myeloid Metaplasia, and Malignant Lymphoma [PDF]

, 1984
E Kelemen, I. Belklinika
openalex   +1 more source

Myelofibrosis

Hematology, 2014
Claire, Harrison, Donal, McLornan
openaire   +2 more sources

Acute myelofibrosis: Report of a case and review of current literature [PDF]

, 1989
Gregory G Marino
openalex   +1 more source